FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Diaceutics PLC Stock AnalysisComprehensive stock analysis for Diaceutics PLC (DIUXF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisDIUXF
DIUXF
Diaceutics PLC
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
DIUXF
Home🔹Stocks🔹Diaceutics PLC

Diaceutics PLC

🇺🇸DIUXF•OTC

Diaceutics PLC

🇺🇸DIUXF•OTC
Market cap
$141.27M
Sentiment

Your view on DIUXF

Mkt Cap
$141.27M
Sentiment
Your view
DIUXF
Diaceutics PLC
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
DIUXF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Diaceutics PLC

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Ryan Keeling
Headquarters
Building Two, Belfast, GB
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Ryan Keeling
Headquarters
Building Two, Belfast, GB
Description

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.

The company also provides DXRX patient journey that enables pharma customers to complete a longitudinal analysis of biomarker testing journeys of individual patients, which identifies opportunities for earlier testing and treatment; DXRX lab benchmarking that enables laboratories to gain competitive edge and compare key criteria to others in the industry providing metrics, such as disease, testing and methodology, market share, turnaround time, and laboratory leadership in these areas; DXRX test reimbursement, which enables pharma customers to engage with laboratories to fund the introduction of novel companion diagnostics, as well as reducing the lag time in test adoption; and DXRX test signal that delivers a real-time alert of a testing event, which allows pharma customers to identify therapeutically actionable patients in the previous weeks.

In addition, it offers diagnostic landscape, planning, implementation, and tracking services; and consulting services for precision medicine diagnostics.

Further, the company provides test standardization, test quality assessment, test report optimization, laboratory tech support, test access and reimbursement, laboratory training, and educational resources services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Diaceutics PLC, and the rating behind it. DIUXF last traded at $1.67, 1436.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Diaceutics PLC. Starting points for Diaceutics PLC: P/E 1436.4, beta 1.08 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Diaceutics PLC. Diaceutics PLC does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Diaceutics PLC. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Diaceutics PLC. Diaceutics PLC has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Diaceutics PLC valued side by side against its closest peers. Diaceutics PLC is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Diaceutics PLC, and how their positions are changing. At a $141.3M market value, institutional positions materially move Diaceutics PLC's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Diaceutics PLC executives and directors. Shares of Diaceutics PLC have traded between $1.37 and $2.51 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Diaceutics PLC. Diaceutics PLC is a $141.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Diaceutics PLC. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Diaceutics PLC. Coverage tracks Diaceutics PLC within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • GREH — Green Rain Energy Holdings Inc.
  • JMDMF — Japan Medical Dynamic Marketing, Inc.

More Medical - Healthcare Information Services companies

  • TXG — 10x Genomics, Inc.
  • UDOC.CN — Unidoc Health Corp.
  • UDOCF — Unidoc Health Corp.
  • UMCN — UMC, Inc.
  • UPHL — UpHealth, Inc.
  • USPS — Ultimate Sports, Inc.
  • VASO — Vaso Corporation
  • VFX.AX — Visionflex Fpo [vfx]
  • VHI.TO — Vitalhub Corp.
  • VHIBF — Vitalhub Corp.
  • VHL.AX — Vitasora Health Limited
  • VRHI — Veri Medtech Holdings Inc.

News

Latest Market News